Terms: = Ovarian cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP AND Treatment
2 results:
1. Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype.
Solar P; Feldman L; Jeong JY; Busingye JR; Sytkowski AJ
Int J Cancer; 2008 Jan; 122(2):281-8. PubMed ID: 17893875
[TBL] [Abstract] [Full Text] [Related]
2. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
[TBL] [Abstract] [Full Text] [Related]
